AI assistant
RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2024
Apr 16, 2024
30849_dirs_2024-04-16_8c081667-d9e3-4940-9b60-97f7f9232575.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2024-04-14
Reporting Person: Mazabraud Yann (EVP, Head of International)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-14 | Common Stock | M | 10375 | — | Disposed | 34870 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-04-14 | Restricted Stock Units | $ | M | 10375 | Disposed | Common Stock (10375) | Direct | |
| 2024-04-15 | Restricted Stock Units | $ | D | 2031 | Disposed | Common Stock (2031) | Direct | |
| 2024-04-15 | Restricted Stock Units | $ | D | 6874 | Disposed | Common Stock (6874) | Direct | |
| 2024-04-15 | Restricted Stock Units | $ | A | 8905 | Acquired | Common Stock (8905) | Direct | |
| 2024-04-15 | Restricted Stock Units | $ | A | 10000 | Acquired | Common Stock (10000) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2: The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date.
F3: The restricted stock units were rescinded and cancelled by mutual agreement of the reporting person and Issuer. The reporting person received French-qualified restricted stock units on April 15, 2024 as consideration for the recission and cancellation of the unvested portion of the restricted stock previously received on February 11, 2021.
F4: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.
F5: The restricted stock units were rescinded and cancelled by mutual agreement of the reporting person and Issuer. The reporting person received French-qualified restricted stock units on April 15, 2024 as consideration for the recission and cancellation of the unvested portion of the restricted stock previously received on February 9, 2022.
F6: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.
F7: The restricted stock units vest in full on April 15, 2025. The restricted stock units have no expiration date.
F8: The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date.